Find a Tender
complete
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS Bristol, North Somerset and South Gloucestershire Integrated Care Board: "SpaMedica". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | NHS Bristol, North Somerset and South Gloucestershire Integrated Care Board | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: NHS Bristol, North Somerset and South Gloucestershire Integrated Care Board
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS Bristol, North Somerset and South Gloucestershire Integrated Care Board. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
1Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 4 active published awards; 4 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS Bristol, North Somerset and South Gloucestershire Integrated Care Board | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published5 Dec 2024, 13:43 GMT | Last source update5 Dec 2024, 13:43 GMT | Recurring procurementNot published |
ClassificationOphthalmologist services | ||
Delivery area | ||
OCIDocds-h6vhtk-04c290 | ||
What is being bought
The service will provide routine elective secondary care services for patients in the following specialities
• Ophthalmology
• Potential for community Age-related Macular Degeneration/Glaucoma monitoring where specifically agreed in advance by the commissioner
• Diagnostics procedures forming part of an agreed pathway
• Direct access to diagnostics procedures, where this has been specifically agreed by the Commissioner
• Cataract, Yag and Oculoplastics
What changed
From the official release history
- Status changed to complete
5 Dec 2024, 13:43 GMT - Official notice release published
5 Dec 2024, 13:43 GMT - Buyer information updated
5 Dec 2024, 13:43 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcancelledPublished valueNot publishedThe service will provide routine elective secondary care services for patients in the following specialities • Ophthalmology • Potential for community Age-related Macular Degeneration/Glaucoma monitoring where specifically agreed in advance by the commissioner • Diagnostics procedures forming part of an agreed pathway • Direct access to diagnostics procedures, where this has been specifically agreed by the Commissioner The services will include, where appropriate; • Pre-treatment e.g., referral processes; triage/clinical assessment; diagnostics; consultation; pre-treatment assessment and / or work up. • Treatment e.g., outpatient/ambulatory/inpatient treatment; joint assessments. • Discharge e.g., expected physical, self-care, psychological capabilities prior to discharge. • Follow up e.g., specialist support post discharge, referrals to other general or specialist services such as GP or District Nurse, self-care requirements for a period up to and including 14 days post discharge. Yag laser capsulotomy is a simple, safe laser treatment to improve eyesight if some fogging recurs after cataract surgery because of lense clouding. Oculoplastics covers conditions affecting displacement of the eyelids, tumours of the eyelids and surrounding areas, lacrimal gland conditions, failure of the tear drainage system, orbital tumours and thyroid eye disease. The Commissioner is directly awarding, following direct award process B, a contract to SpaMedica in accordance with the criteria outlined in Regulation (9) of the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award This is an activity-based contract with no guaranteed value. The contract has been awarded for the period 01/04/2024 - 31/03/2026 with no provision for extension includedContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
5 Dec 2024, 13:43 GMT - Award active
Not published · Not published - Contract active
Signed 1 Apr 2024, 00:00 BST · £0
Commercial outcome and competition
Awards SpaMedica Limited Not published · Not published · active |
Contracts SpaMedica £0 · signed 1 Apr 2024, 00:00 BST · active |
Bid statistics bids: 1 (lot 1) |
Buyer and organisations in this procedure
NHS Bristol, North Somerset and South Gloucestershire Integrated Care Board
Contracting authority GB-FTS-132086Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleThe procurement has been conducted in line with Right to Choose requirements. |